| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:702.)
© 2009 American Heart Association, Inc.
Original Contributions |
From the Tulane Center for Cardiovascular Health and the Department of Epidemiology (L.R., W.C., S.R.S., M.S., H.W., A.T., G.S.B.), Tulane University Health Sciences Center, New Orleans, La; and the Department of Ultrasound Diagnostics (L.R.), the First Affiliated Hospital, School of Medicine, Xian Jiaotong University, Xian, China.
Correspondence to Gerald S. Berenson, MD, Tulane Center for Cardiovascular Health, 1440 Canal Street, Suite 1829, New Orleans, LA 70112. E-mail berenson{at}tulane.edu
| Abstract |
|---|
|
|
|---|
Methods— The study cohort included 734 white and 306 black subjects, aged 20 to 43 years, enrolled in the Bogalusa Heart Study. The common carotid artery lumen diameter at diastole and intima media thickness (IMT) were measured by M- and B-mode ultrasonography, respectively.
Results— As a group, blacks versus whites (3.44 mm/m versus 3.37 mm/m, P=0.002) and males versus females (3.45 mm/m versus 3.35 mm/m, P<0.001) had greater height-adjusted lumen diameter. In multivariate analyses of total sample, body mass index, mean arterial pressure, heart rate, and carotid IMT were independent predictors of height-adjusted lumen diameter. The magnitude of the effects of mean arterial pressure and carotid IMT on height-adjusted lumen diameter was significantly different between races with blacks showing greater slopes (difference in slopes: P=0.011 for mean arterial pressure; P=0.033 for IMT); interaction effects of body mass index and mean arterial pressure with sex on height-adjusted lumen diameter were also noted with males showing steeper slopes (difference in slopes: P=0.003 for body mass index; P=0.005 for mean arterial pressure). In addition, the lumen diameter–carotid IMT relationship was stronger in hypertensives than in normotensives (difference in slopes: P=0.038).
Conclusions— Common carotid artery lumen diameter is influenced by carotid artery IMT, adiposity, and blood pressure in a race- and sex-specific manner in asymptomatic younger adults, which may have implications for preventive cardiology.
Key Words: cardiovascular risk factors carotid artery intima media thickness lumen diameter younger adults
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
General Examinations
Standardized protocols were used by trained examiners.13 Height and weight were measured twice, and the mean values were used to calculate body mass index (BMI=weight in kilograms divided by the square of the height in meters) as a measure of overall adiposity. Blood pressure was measured in triplicate with a mercury sphygmomanometer by 2 nurses while subjects were seated and relaxed. The first and fifth Korotkoff phases were used to determine systolic and diastolic blood pressure, respectively; means of 6 replicate readings were used. Forced values (140/90 mm Hg) were assigned for systolic and diastolic blood pressure, respectively, to subjects (n=67) who were on medications for hypertension at the time of examination. Mean arterial pressure (MAP) was calculated as diastolic blood pressure+one third pulse pressure. Hypertension was defined as systolic and/or diastolic blood pressure
140/90 mm Hg or on antihypertensive medications.
Laboratory Analysis
Subjects were instructed to fast for 12 hours before screening, and the compliance was determined by interview on the morning of examination. Serum cholesterol was determined enzymatically on the Hitachi 902 Automatic Nalyzer (Roche Diagnostics, Indianapolis, Ind). Serum lipoprotein cholesterols were analyzed by a combination of heparin–calcium precipitation and agar–agarose gel electrophoresis procedures.14 The laboratory is being monitored for precision and accuracy of lipid measurements by the agencys surveillance program of the Centers for Disease Control and Prevention, Atlanta, Ga. Plasma glucose was measured by a glucose oxidase method as part of the multiple chemistry profile (SMA20) in the multichannel Olympus Au-5000 Analyzer (Olympus, Lake Success, NY). Intraclass correlation coefficients, a measure of reproducibility of the entire process from blood collection to data processing, between the blind duplicate values (n=103) were 0.98 for total cholesterol, 0.99 for high-density lipoprotein cholesterol (HDL-C), and 0.98 for glucose. Forced values of 240 mg/dL for total cholesterol and 126 mol/dL for glucose were assigned to subjects who were on medications for dyslipidemia (n=26) and diabetes (n=19) at the time of examination, respectively.
Carotid Ultrasonography
Carotid ultrasound measurements were done on a Toshiba Ultrasound instrument (Power Vision Toshiba SSH-380 ultrasound system; Toshiba America Medical Systems, Carrollton, Texas) using a 7.5-MHz linear array transducer. Images were recorded on right and left common carotid according to previously developed protocols for the Atherosclerosis Risk in Communities study.15 Images were recorded on super VHS video tapes and read by certified readers from the Vascular Ultrasound Research Laboratory in Wake Forest using a semiautomatic ultrasound imaging. The common carotid lumen diameter at diastole was measured by M-mode ultrasound. The lumen diameter between the near and far wall intima media interfaces was imaged along the vessel length (ie, the 1-cm segment proximal to the dilation of the carotid bulb) on both sides. Carotid IMT at diastole from the far walls of the common carotid artery on both sides was measured by B-mode ultrasound. The mean values of left- and right-sided lumen diameter and carotid IMT readings were used for the analyses. If bilateral images were not available, the value of one side was used as the mean.
Statistical Methods
All data analyses were performed using SAS 9.1. Total cholesterol/HDL-C ratio was log-transformed to improve the normality of distribution for correlation and regression analyses; however, their mean values in original scales are presented in Table 1 for description. Differences in mean values of study variables between race–sex groups were tested by analysis of covariance models. The correlations of the height-adjusted lumen diameter with carotid IMT and CV risk factors were assessed using Pearson correlation coefficients; the difference in the correlation coefficients between blacks and whites was tested with Fishers Z-test. Carotid lumen diameter was adjusted for height by using a ratio of the diameter to height (mm/m) because of their strong correlation.8,11,16 The impact of the correlates on carotid lumen diameter was examined by multivariate regression models by race separately and in the total sample. Trajectories of carotid lumen diameter with CV risk variables in race or sex groups or among hypertensives versus normotensives were estimated using a separate slopes model. The differences in slopes between groups (interaction effects on the lumen diameter) were tested using a homogeneity-of-slopes model.
|
| Results |
|---|
|
|
|---|
Pearson correlation coefficients of height-adjusted carotid lumen diameter with carotid IMT and CV risk factor variables are presented in Table 2. BMI, MAP, and carotid IMT were significantly correlated with the lumen diameter in both races and the total sample. Total cholesterol/HDL-C ratio was correlated with the lumen diameter in whites and the total sample; heart rate in whites; and glucose in whites, males, and the total sample. The correlation coefficients were marginally different between blacks and whites for MAP (P=0.066) and carotid IMT (P=0.095) and between males and females for BMI (P=0.062); the correlation coefficients significantly differed between males and females for MAP (P=0.007).
|
Standardized regression coefficients of height-adjusted carotid lumen diameter on carotid IMT and CV risk factors are presented in Table 3. BMI and carotid IMT were significantly and positively associated with carotid lumen diameter in both races; sex and heart rate in whites only; and MAP in blacks only. Based on the magnitude of standardized regression coefficients in the total sample, BMI, carotid IMT, MAP, and sex (male>female) were, in that order, associated with the height-adjusted carotid lumen diameter.
|
Trajectories of carotid lumen diameter with CV risk factor variables by race and sex were examined further in a multivariate model. As shown in Figure 1, although the height-adjusted carotid lumen diameter significantly increased with increasing BMI in both males and females, the slope was significantly steeper in males than in females (difference in slopes: P=0.003). Similarly, males also showed a significantly greater slope of the height-adjusted carotid lumen diameter with increasing MAP than females (difference in slopes: P=0.005). In Figure 2, blacks versus whites showed significantly greater slopes of the height-adjusted carotid lumen diameter with increasing MAP (difference in slopes: P=0.011) and carotid IMT (difference in slopes: P=0.033). In Figure 3, hypertensives versus normotensives showed significantly higher levels and greater slope of the height-adjusted carotid lumen diameter with increasing carotid IMT (difference in slopes: P=0.038). The hypertension–carotid IMT interaction did not differ significantly between race or sex groups.
|
|
|
| Discussion |
|---|
|
|
|---|
Although carotid IMT, a determinant of the lumen diameter, was significantly higher in blacks than in whites in this as well as previous studies, including our own,17,21,22 race was not an independent predictor of lumen diameter in a multivariate model. Clarkson et al2 found in an autopsy study that blacks versus whites had larger coronary artery lumina despite having a larger intimal area. Multivariate predictors of lumen area in their study were intimal area, height, race, and history of CV disease. They concluded that such compensatory luminal enlargement in blacks versus whites may account for the relatively less clinical ischemic heart disease observed in blacks.23,24 Later studies confirmed these conclusions.25,26 Of note, in the current study, the effects of carotid IMT and MAP on lumen diameter were relatively stronger in blacks versus whites, suggesting that the adverse effects of these risk variables on the arterial wall were more than compensated by excess luminal enlargement in this racial group.
With respect to sexual dimorphism in this study cohort, female sex is significantly associated with smaller lumen diameter, independent of carotid IMT and other covariates included in the multivariate model. Earlier studies have shown smaller carotid IMT and lumen diameter in females versus males2,5,7,11; whether this could explain the observed relatively lower impacts of BMI and MAP on lumen diameter in females versus males is not clear. It should be noted that severity of coronary artery disease is known to be less in women, especially white women, of reproductive age compared with men; this disparity eventually disappear in postmenopausal woman.27 Findings from many previous studies supported the estrogen protection hypothesis.27,28 Observations on the sex difference in the relationship of BMI and MAP to lumen diameter in this study suggest that sex hormones might be involved in the complex regulation of the vascular remodeling.
In the current study, BMI was found to be positively associated with enlarged carotid lumen diameter independent of other CV risk variables. Because this study is cross-sectional and observational in nature, it cannot address the issue of causality or underlying mechanisms, but can only suggest possible reasons for the observed relationships. Excess adiposity could induce luminal enlargement through a variety of intermediated factors. These included, among others, impaired arterial compliance, increases in intravascular volume and blood pressure, activation of endothelial dysfunction and the adipose renin–angiotensin–aldosterone system, and excess inflammatory response.29–34
Increased shear stress at intimal thickening of the stenotic site is thought to induce luminal enlargement to normalize the wall shear stress.35 Matrix metalloproteinases generated during disease progression may play a role in vascular remodeling by degrading the extracellular matrix, which can lead to weakening of the arterial wall and the attendant luminal enlargement.36 With respect to blood pressure, sustained excess blood pressure is known to produce mechanical stress and medial degeneration resulting in impaired arterial compliance; and such reduction in compliance of large arteries might bring about a large diastolic lumen diameter, known as caliber increase.37,38 In the current study, the carotid IMT–lumen diameter relationship was significantly stronger in hypertensives than in normotensives, suggesting a synergistic influence of blood pressure and arterial thickening on lumen enlargement. This observation is consistent with the finding from a previous study39 and supports the concepts mentioned.
In conclusion, vascular remodeling, as measured by common carotid artery lumen diameter, is influenced independently by IMT, adiposity, and blood pressure among asymptomatic younger adults in a race- and sex-specific manner. As part of prevention cardiology, future studies are needed to ascertain the potential value of carotid lumen diameter in conjunction with IMT and CV risk factors in identifying risk associated with early subclinical atherosclerosis in younger adults.
| Acknowledgments |
|---|
This study was supported by grants 0855082E and 0555168B from the American Heart Association, HL-38844 from the National Heart, Lung, Blood Institute, and AG-16592 from the National Institute on Aging.
Disclosures
None.
Received July 15, 2008; accepted July 25, 2008.
| References |
|---|
|
|
|---|
2. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodeling of coronary arteries in human and nonhuman primates. JAMA. 1994; 271: 289–294.
3. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological of arterial remodeling in coronary atherosclerosis. Circulation. 2002; 105: 297–303.
4. Losordo DW, Rosenfield K, Kaufman J, Pieczek A, Isner JM. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation. 1994; 89: 2570–2577.
5. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, Riley W, Heiss G. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1996; 27: 69–75.
6. Polak JF, Kronmal RA, Tell GS, O'Leary DH, Savage PJ, Gardin JM, Rutan GH, Borhani NO. Compensatory increase in common carotid artery diameter. Relation to blood pressure and artery intima-media thickness in older adults. Cardiovascular Health Study. Stroke. 1996; 27: 2012–2015.
7. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years. Stroke. 1996; 27: 654–660.
8. Jensen-Urstad K, Jensen-Urstad M, Johansson J. Carotid artery diameter correlates with risk factors for cardiovascular disease in a population of 55-year-old subjects. Stroke. 1999; 30: 1572–1576.
9. Wildman RP, Mehta V, Thompson T, Brockwell S, Sutton-Tyrrell K. Obesity is associated with larger arterial diameters in Caucasian and African-American young adults. Diabetes Care. 2004; 27: 2997–2999.
10. Eigenbrodt ML, Bursac Z, Rose KM, Couper D, Tracy RE, Evans GW, Brancati F, Mehta JL. Common carotid arterial interadventitial distance (diameter) as an indictor of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk In Community cohort Limited Access Data (ARICLAD), 1987–89. Cardiovascular Ultrasound. 2006; 4: 1–10.[CrossRef][Medline] [Order article via Infotrieve]
11. Sass C, Herbeth B, Chapet O, Siest G, Visvikis S, Zannad F. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens. 1998; 16: 1593–1602.[CrossRef][Medline] [Order article via Infotrieve]
12. The Bogalusa Heart Study 20th Anniversary Symposium. Am J Med Sci. 1995; 310: S1–S138.[Medline] [Order article via Infotrieve]
13. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV. Cardiovascular Risk Factors in Children—The Early Natural History of Atherosclerosis and Essential Hypertension (editorial assistance: Andrews C, Hester HE). New York: Oxford University Press; 1980: 47–123.
14. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, ed. CRC Handbook of Electrophoresis Vol III: Lipoprotein Methodology and Human Studies. Boca Raton, FL: CRC Press; 1983: 185–203.
15. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk In Communities (ARIC) cohort. The ARIC Study Group. J Neuroimaging. 1991; 1: 168–172.[Medline] [Order article via Infotrieve]
16. Krejza J, Arkuszewski M, Kasner SE, Weigele J, Ustymowicz A, Hurst RW, Cucchiara BL, Messe SR. Carotid artery diameter in men and women and the relation to body and neck size. Stroke. 2006; 37: 1103–1105.
17. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS; Bogalusa Heart Study. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol. 2002; 90: 953–958.[CrossRef][Medline] [Order article via Infotrieve]
18. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk In Communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997; 146: 483–494.
19. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340: 14–22.
20. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR III, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000; 101: E16–E22.[Medline] [Order article via Infotrieve]
21. Manolio TA, Burke GL, Psaty BM, Newman AB, Haan M, Powe N, Tracy RP, O'Leary DH. Black–white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol. 1995; 48: 1141–1152.[CrossRef][Medline] [Order article via Infotrieve]
22. D'Agostino RB Jr, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke. 1996; 27: 1744–1749.
23. Strong JP, McGill HC Jr. The natural history of coronary atherosclerosis. Am J Pathol. 1962; 40: 37–49.[Medline] [Order article via Infotrieve]
24. Mann GV, Spoerry A, Gray M, Jarashow D. Atherosclerosis in the Masai. Am J Epidemiol. 1972; 95: 26–37.
25. Crook ED, Clark BL, Bradford ST, Golden K, Calvin R, Taylor HA Jr, Flack JM. From 1960s Evans County, Georgia, to present-day Jackson, Mississippi: an exploration of the evolution of cardiovascular disease in African Americans. Am J Med Sci. 2003; 325: 307–314.[CrossRef][Medline] [Order article via Infotrieve]
26. Budoff MJ, Yang TP, Shavelle RM, Lamont DH, Brundage BH. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol. 2002; 39: 408–412.
27. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997; 95: 252–264.
28. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003; 24: 313–340.
29. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003; 42: 468–473.
30. Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep. 2000; 2: 139–147.[Medline] [Order article via Infotrieve]
31. Engeli S, Sharma AM. The renin–angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001; 79: 21–29.[CrossRef][Medline] [Order article via Infotrieve]
32. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89: 2548–2556.
33. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005; 45: 9–14.
34. Rajala MW, Scherer PE. Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003; 144: 3765–3773.
35. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994; 330: 1431–1438.
36. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, Borst C. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis. 2000; 150: 245–253.[CrossRef][Medline] [Order article via Infotrieve]
37. Glagov S, Vito R, Giddens DP, Zarins CK. Micro-architecture and composition of artery walls: relationship to location, diameter and the distribution of mechanical stress. J Hypertens Suppl. 1992; 10: S101–S104.[CrossRef][Medline] [Order article via Infotrieve]
38. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension. 1999; 33: 1392–1398.
39. Chironi G, Gariepy J, Denarie N, Balice M, Megnien JL, Levenson J, Simon A. Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol. 2003; 23: 1460–1464.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |